The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review

Non-alcoholic fatty liver disease (NAFLD) is currently considered an important component of metabolic syndrome (MetS). The spectrum of NAFLD includes conditions that range from simple hepatic steatosis to non-alcoholic steatohepatitis. NAFLD is correlated with liver-related death and is predicted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Borém, Luciana M. A., Neto, João F. R., Brandi, Igor V., Lelis, Deborah F, Santos, Sergio H. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091617/
https://www.ncbi.nlm.nih.gov/pubmed/29636553
http://dx.doi.org/10.1038/s41440-018-0040-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091617/
https://www.ncbi.nlm.nih.gov/pubmed/29636553
http://dx.doi.org/10.1038/s41440-018-0040-6

Ejemplares similares